KRYPROLIS

Serial Number 85040913
602

Registration Progress

Application Filed
May 17, 2010
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

KRYPROLIS

Basic Information

Serial Number
85040913
Filing Date
May 17, 2010
Abandonment Date
March 8, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 16, 2011
Classes
005 042

Rights Holder

Onyx Pharmaceuticals, Inc.

03
Address
2100 Powell Street
Emeryville, CA 94608

Ownership History

Onyx Pharmaceuticals, Inc.

Original Applicant
03
Emeryville, CA

Legal Representation

Attorney
Anne H. Peck

Application History

10 events
Date Code Type Description Documents
Apr 18, 2011 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Apr 16, 2011 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 5, 2010 CPRA R PRIORITY ACTION WRITTEN Loading...
Sep 5, 2010 GPRA F PRIORITY ACTION E-MAILED Loading...
Sep 5, 2010 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Aug 29, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 8, 2010 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 8, 2010 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
May 21, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Pharmaceutical research and development; medical and scientific research , namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042